DXCM DexCom, Inc. - Common Stock
$90,75
Cena · Sie 18, 2026
Dane fundamentalne na dzień Lip 30, 2026
Zakres 52 tyg.
$54–$92
97% of range
Ocena Analityków
BUY
36 analysts
Cena Docelowa
$93
+3% upside
P/E (TTM)
43.5
ROE
31.4%
Marża Zysku Netto
17.9%
O DexCom, Inc. - Common Stock Przegląd firmy z Wikipedii
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
Czytaj więcej
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
History
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second-generation product, the Seven Continuous Glucose Monitoring System, in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.
During February 2009, Dexcom received approval for the Seven Plus Continuous Glucose Monitor, its new continuous glucose monitoring system, from the FDA. This product received a CE mark in November 2009. In 2013, development work for integration with Insulet was discontinued. Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its forthcoming G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. The G5 was approved in 2016 by the FDA for use as a standalone device, while the G6 gained approval in 2018.
Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over. This device improved hypoglycemic accuracy by 30%. It also offered a longer range of transmission between the sensor and receiver, as well as a color LCD. The G4 Platinum was approved by the FDA for use in patients ages 2–17 in February 2014. Dexcom received FDA approval in January 2015 for the G4 Platinum with Share, which enabled the sharing of CGM data with up to five other people using the "Share" and "Follow" smartphone apps.
The Dexcom G5 was approved in August 2015 by the FDA for use as a standalone device, the G5 has Bluetooth integrated into its transmitter, enabling it to send data to a mobile device. This allows for use of the device without the standalone receiver. The Dexcom G5 received a CE mark in September 2015.
Dexcom went public in 2005 and is listed on the Nasdaq Global Select Market stock exchange under the ticker symbol DXCM. On April 20, 2020, Dexcom became a component of the Nasdaq-100, replacing American Airlines Group in the index.
The Dexcom G7 was approved in December 2022 by the FDA for use as a standalone device. The Dexcom G7 15-Day is the most accurate currently approved CGM in the U.S.
Awards and recognition
In October 2024, Time Magazine named Dexcom Stelo's over-the-counter glucose monitor one of the year's best inventions.
Partnerships
Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7
Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. Tandem Diabetes Care received FDA approval in December 2019 for Control-IQ, a closed-loop technology that uses Tandem's t:slim X2 insulin pump and the Dexcom G6 "to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with Type 1 diabetes."
In June 2019, Dexcom announced a collaboration with Companion Medical to enable the exchange of CGM data from Dexcom with insulin data from InPen into both companies' software applications.
Dexcom entered into a partnership with Livongo, a digital chronic care management company, in January 2020 to share CGM data from the Dexcom G6 with Livongo's platform. This integration allowed Livongo to incorporate the CGM data along with other patient data.
In February 2020, Dexcom and Insulet Corporation signed a non-exclusive, global agreement to combine current and future Dexcom continuous glucose monitoring systems with Insulet's tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery. This allowed the ability to adjust insulin doses based on Insulet's algorithm or through their smartphone.
The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management.
In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.
Venture capital arm
In early 2021, Dexcom launched Dexcom Ventures, a venture capital arm focused on emerging continuous glucose monitoring technologies and devices measuring the levels of other types of substances and analytes. In practice, Dexcom Ventures has also invested in cybersecurity platforms for the software used in medical devices.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
DXCM Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$90.75
Kapitalizacja Rynkowa
$35.02B
P/E (TTM)
43.5
EPS (TTM)
$2.09
Przychody (TTM)
$4.66B
Stopa dywidendy
—
ROE
31.4%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$54 – $92
DXCM Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$4.66B
2016-12-31
→
2025-12-31
EPS
$2.09
2017-12-31
→
2025-12-31
Wolny przepływ pieniężny
$1.08B
2016-12-31
→
2025-12-31
Marże
17.9%
2018-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
DXCM
Mediana porównawcza
P/E (TTM)
43.5
26.3
P/S (TTM)
7.5
4.4
P/B
12.8
5.3
Price / FCF (Cena / FCF)
32.5
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
DXCM
Mediana porównawcza
Gross Margin (Marża brutto)
60.1%
63.1%
Operating Margin (Marża Operacyjna)
19.6%
—
Net Profit Margin (Marża Zysku Netto)
17.9%
15.6%
ROA
13.0%
7.6%
ROE
31.4%
15.0%
ROIC
25.5%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
DXCM
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
1.9
1.7
Quick Ratio (Wskaźnik Szybkości)
1.0
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
DXCM
Mediana porównawcza
Revenue YoY (Przychody R/R)
15.6%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
17.0%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
19.3%
—
EPS YoY
47.2%
—
Net Income YoY (Zysk Netto R/R)
45.1%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
DXCM
Mediana porównawcza
DXCM Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
36 analityków
- Mocne kupno 15 41,7%
- Kup 16 44,4%
- Trzymaj 5 13,9%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
25 analityków · 2026-08-14
Mediana
$93.00
Teraz
$90.75
Niski
$79.00
Wysoki
$115.00
Średni cel
$93.00
+2,5%
Średnia cel
$93.44
+3,0%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.05%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $0.70 | $0.62 | 0.08% |
| 31 marca 2026 | $0.56 | $0.48 | 0.08% |
| 31 grudnia 2025 | $0.56 | $0.48 | 0.08% |
| 30 września 2025 | $0.61 | $0.58 | 0.03% |
| 30 czerwca 2025 | $0.48 | $0.45 | 0.03% |
| 31 marca 2025 | $0.32 | $0.33 | -0.01% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | · | · | |
| Cost of Revenue | $1.86B | $1.59B | $1.33B | $1.03B | $768M | $647M | $544M | $368M | $226M | $195M | $124M | $83M | |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B | $1.28B | $932M | $664M | $492M | $378M | $278M | $176M | |
| R&D Expense | $599M | $552M | $506M | $484M | $517M | $360M | $274M | $200M | $185M | $156M | $138M | $69M | |
| SG&A Expense | $1.29B | $1.29B | $1.19B | $1.01B | $810M | $618M | $516M | $433M | $349M | $286M | $198M | $128M | |
| Operating Expenses | $1.89B | $1.84B | $1.69B | $1.49B | $1.41B | $981M | $789M | $850M | $535M | $442M | $336M | $198M | |
| Operating Income | $912M | $600M | $598M | $391M | $266M | $300M | $142M | $-186M | $-42M | $-64M | $-57M | $-22M | |
| Interest Expense | · | · | $20M | $19M | $19M | $18M | $60M | $23M | $13M | $700.0K | $400.0K | $800.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $3M | $400.0K | $0 | $0 | |
| Other Non-op | $177M | $109M | $113M | $-400.0K | $-9M | $16M | $26M | $2M | $7M | $-700.0K | $0 | $0 | |
| Pretax Income | $1.09B | $709M | $710M | $391M | $257M | $298M | $104M | $-126M | $-49M | $-65M | $-58M | $-22M | |
| Income Tax | $252M | $133M | $169M | $50M | $40M | $-252M | $3M | $600.0K | $2M | $700.0K | $100.0K | $100.0K | |
| Net Income | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| EPS (Basic) | $2.14 | $1.46 | $1.40 | $0.88 | $0.56 | $1.46 | $1.11 | $-1.44 | $-0.58 | · | · | · | |
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · | |
| Shares (Basic) | 390,200,000 | 393,600,000 | 386,000,000 | 389,400,000 | 386,900,000 | 377,500,000 | 91,100,000 | 88,200,000 | 86,300,000 | · | · | · | |
| Shares (Diluted) | 405,500,000 | 412,700,000 | 425,500,000 | 427,500,000 | 428,800,000 | 420,400,000 | 92,300,000 | 88,200,000 | 86,300,000 | · | · | · | |
| EBITDA | $1.16B | $818M | $784M | $547M | $368M | $367M | $191M | $-157M | $-26M | $-49M | $-46M | $-13M |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $918M | $606M | $566M | $642M | $1.05B | $818M | $446M | $1.14B | $442M | $94M | $86M | $72M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $93M | $23M | · | · | |
| Receivables | $1.22B | $1.01B | $974M | $713M | $514M | $428M | $286M | $227M | $134M | $102M | $74M | $42M | |
| Inventory | $629M | $543M | $560M | $307M | $357M | $235M | $120M | $71M | $45M | $45M | $35M | $16M | |
| Prepaid Expense | $189M | $174M | $168M | $193M | $82M | $54M | $30M | $16M | $17M | $9M | $7M | $4M | |
| Other Current Assets | $29M | $29M | $49M | $27M | $27M | · | · | · | · | · | · | · | |
| Current Assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B | $3.42B | $1.97B | $1.70B | $745M | $280M | $231M | $146M | |
| PP&E (Net) | · | · | · | $1.06B | $802M | $515M | $321M | $183M | $146M | $109M | $55M | $31M | |
| PP&E (Gross) | · | · | · | $1.42B | $1.03B | $670M | $426M | $263M | $200M | $157M | $93M | $64M | |
| Accum. Depreciation | · | · | · | $363M | $232M | $154M | $105M | $80M | $55M | $47M | $38M | $33M | |
| Goodwill | $24M | $23M | $25M | $26M | $26M | $19M | $19M | $19M | $12M | $11M | $4M | $3M | |
| Intangibles | $71M | $103M | $134M | $173M | $32M | · | · | · | · | $200.0K | $2M | $3M | |
| Other Non-current Assets | $279M | $173M | $75M | $47M | $10M | $21M | $14M | $15M | $2M | $2M | $100.0K | $600.0K | |
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Current Liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $721M | $614M | $360M | $222M | $139M | $102M | $67M | $41M | |
| Capital Leases | $73M | $65M | $80M | $95M | $99M | $102M | $72M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $5M | $6M | $0 | · | · | · | · | · | · | |
| Other Non-current Liabilities | $137M | $148M | $126M | $128M | $90M | $81M | $20M | $20M | $18M | $17M | $4M | $2M | |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B | $1.51B | $1.25B | $485M | $119M | $71M | $44M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Retained Earnings | $2.43B | $1.60B | $1.02B | $480M | $139M | $-78M | $-696M | $-799M | $-672M | $-621M | $-555M | $-498M | |
| Treasury Stock | $2.08B | $1.58B | $2.45B | $595M | $206M | $100M | $100M | $100M | $0 | · | · | · | |
| AOCI | $115M | $-8M | $-17M | $-12M | $500.0K | $3M | $2M | $2M | $-3M | $-1M | $-300.0K | $-100.0K | |
| Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.55B | $883M | $663M | $419M | $284M | $221M | $140M | |
| Liabilities + Equity | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Shares Outstanding | 384,800,000 | 390,700,000 | 385,400,000 | 386,300,000 | 388,000,000 | 384,400,000 | 366,400,000 | 90,000,000 | 87,000,000 | 84,600,000 | 81,700,000 | 77,300,000 |
Przepływy pieniężne 19
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $252M | $218M | $186M | $156M | $102M | $67M | $49M | $29M | $16M | $15M | $11M | $8M | |
| Stock-based Comp | $160M | $170M | $151M | $126M | $113M | $119M | $103M | $102M | $106M | $111M | $83M | $50M | |
| Deferred Tax | $182M | $-44M | $-55M | $-22M | $16M | $-260M | $200.0K | $-2M | $0 | $-200.0K | $0 | $0 | |
| Amort. of Intangibles | $4M | $7M | $8M | $8M | $4M | $2M | · | · | · | $700.0K | $500.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Other Non-cash | $11M | $69M | $-75M | $68M | $77M | $73M | $62M | $122M | $20M | $-4M | $13M | $-12M | |
| Operating Cash Flow | $1.44B | $990M | $748M | $670M | $442M | $476M | $314M | $123M | $92M | $56M | $49M | $24M | |
| CapEx | $364M | $359M | $237M | $365M | $389M | $199M | $180M | $67M | $66M | $56M | $33M | $16M | |
| Investing Cash Flow | $536M | $-208M | $-507M | $-522M | $-216M | $-1.02B | $-1.02B | $-140M | $-144M | $-56M | $-52M | $-17M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | $-2M | $-2M | $-2M | |
| Stock Issued | $28M | $28M | $27M | $22M | $20M | $15M | $12M | $11M | $10M | $10M | $19M | $24M | |
| Stock Repurchased | $500M | $750M | $689M | $558M | $0 | $0 | $0 | $100M | $0 | $0 | · | · | |
| Net Stock Activity | $-472M | $-722M | $-662M | $-535M | $20M | $15M | $12M | $-89M | $10M | $10M | $19M | $24M | |
| Financing Cash Flow | $-1.69B | $-735M | $-319M | $-552M | $10M | $912M | $11M | $710M | $399M | $8M | $17M | $22M | |
| Net Change in Cash | $312M | $40M | $-76M | $-410M | $235M | $372M | $-691M | $696M | $347M | $8M | $14M | $29M | |
| Taxes Paid | $94M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M | $277M | $134M | $56M | $26M | $500.0K | $16M | $7M | |
| Levered FCF | · | · | $496M | $288M | $-36M | $91M | $76M | $33M | $13M | $-207.6K | $15M | $7M |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | · | · | · | · | |
| Operating Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | · | · | · | · | |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 6.3% | 25.6% | 6.9% | -12.3% | · | · | · | · | |
| Pretax Margin | 23.4% | 17.6% | 19.6% | 13.4% | 7.1% | 11.7% | 7.1% | -12.3% | · | · | · | · | |
| EBITDA Margin | 25.0% | 20.3% | 21.6% | 18.8% | 15.0% | 19.0% | 12.9% | -15.2% | · | · | · | · | |
| ROA | 13.0% | 9.0% | 9.3% | 6.6% | 3.4% | 14.8% | 4.7% | -9.0% | -7.7% | -18.9% | -24.2% | -14.6% | |
| ROE | 31.4% | 28.2% | 25.0% | 17.2% | 7.4% | 29.7% | 12.3% | -20.7% | -14.3% | -26.0% | -31.9% | -20.0% | |
| ROIC | 25.5% | 23.2% | 22.0% | 16.0% | 10.5% | 36.0% | 15.6% | -28.2% | -10.5% | -22.8% | -25.9% | -15.4% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 | 5.6 | 5.5 | 7.6 | 5.4 | 2.7 | 3.5 | 3.6 | |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 | 2.0 | 2.0 | 6.1 | 4.8 | 2.1 | 2.4 | 1.8 | |
| Interest Coverage | · | · | 29.4 | 21.0 | 2.6 | 3.5 | 2.4 | -8.2 | -3.3 | -91.3 | -142.8 | -26.9 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Inventory Turnover | 3.2 | 2.9 | 3.1 | 3.1 | 2.6 | 3.6 | 5.7 | 6.3 | 5.0 | 4.8 | 4.8 | 6.6 | |
| Receivables Turnover | 4.2 | 4.1 | 4.3 | 4.7 | 5.2 | 5.4 | 5.8 | 5.7 | · | · | · | · |
Stopy Wzrostu 9
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 17.0% | 18.1% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 47.2% | 9.2% | 58.5% | 54.7% | -60.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.6% | 38.9% | -0.76% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 45.1% | 6.4% | 58.7% | 57.3% | -60.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 34.8% | 38.5% | -0.50% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 8.8% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | $402M | $259M | |
| Net Income TTM | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| Market Cap | $25.54B | $30.38B | $47.82B | $43.74B | $13.02B | $8.88B | $5.01B | $2.70B | $1.25B | $1.26B | $1.67B | $1.06B | |
| P/E | 31.8 | 54.8 | 95.5 | 138.1 | 253.3 | 69.5 | 49.7 | -20.8 | -24.7 | · | · | · | |
| P/S | 5.5 | 7.5 | 13.2 | 15.0 | 5.3 | 4.6 | 3.4 | 2.6 | 1.7 | 2.2 | 4.2 | 4.1 | |
| P/B | 9.3 | 14.5 | 23.1 | 20.5 | 5.8 | 4.9 | 5.7 | 4.1 | 3.0 | 4.4 | 7.6 | 7.6 | |
| P / Tangible Book | 9.6 | 15.4 | 25.1 | 22.6 | 6.6 | 5.8 | · | · | · | · | · | · | |
| P / Cash Flow | 17.7 | 30.7 | 63.9 | 65.3 | 29.4 | 18.7 | 15.9 | 21.9 | 13.6 | 22.5 | 34.1 | 45.1 | |
| P / FCF | 23.7 | 48.2 | 93.4 | 143.6 | 244.3 | 32.1 | 37.2 | 48.0 | 48.0 | 2525.3 | 106.5 | 143.8 | |
| Earnings Yield | 3.1% | 1.8% | 1.1% | 0.72% | 0.39% | 1.4% | 2.0% | -4.8% | -4.0% | · | · | · |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994M | $1.00B | $921M | $1.03B | $975M | $871M | $742M | $815M | $770M | |
| Cost of Revenue | $478M | $442M | $467M | $478M | $468M | $447M | $458M | $400M | $378M | $359M | $378M | $352M | $325M | $279M | $274M | $275M | |
| Gross Profit | $830M | $750M | $793M | $731M | $689M | $589M | $656M | $594M | $627M | $562M | $657M | $623M | $546M | $463M | $541M | $494M | |
| R&D Expense | $153M | $145M | $148M | $158M | $148M | $145M | $140M | $135M | $136M | $142M | $136M | $131M | $119M | $119M | $116M | $110M | |
| SG&A Expense | $359M | $350M | $322M | $331M | $328M | $310M | $327M | $306M | $333M | $319M | $304M | $286M | $299M | $296M | $305M | $235M | |
| Operating Expenses | $512M | $495M | $470M | $489M | $476M | $455M | $467M | $442M | $469M | $461M | $440M | $418M | $418M | $415M | $416M | $347M | |
| Operating Income | $318M | $255M | $323M | $242M | $213M | $134M | $189M | $152M | $158M | $101M | $217M | $206M | $128M | $47M | $125M | $148M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $6M | $5M | · | $5M | |
| Other Non-op | $-800.0K | $14M | $18M | $110M | $28M | $21M | $22M | $25M | $30M | $31M | $29M | $35M | $31M | $17M | $-1M | $-1M | |
| Pretax Income | $318M | $270M | $341M | $352M | $241M | $154M | $211M | $177M | $188M | $132M | $246M | $240M | $159M | $64M | $133M | $146M | |
| Income Tax | $68M | $70M | $73M | $68M | $61M | $49M | $60M | $43M | $44M | $-14M | $-10M | $120M | $43M | $16M | $41M | $45M | |
| Net Income | $249M | $200M | $267M | $284M | $180M | $105M | $152M | $135M | $144M | $146M | $256M | $121M | $116M | $49M | $92M | $101M | |
| EPS (Basic) | $0.65 | $0.52 | $0.68 | $0.73 | $0.46 | $0.27 | $0.38 | $0.34 | $0.36 | $0.38 | $0.66 | $0.31 | $0.30 | $0.13 | $0.24 | $0.26 | |
| EPS (Diluted) | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 | $0.35 | $0.36 | $0.61 | $0.29 | $0.28 | $0.12 | $0.23 | $0.24 | |
| Shares (Basic) | 382,200,000 | 385,100,000 | -784,100,000 | 391,100,000 | 392,100,000 | 391,100,000 | -790,000,000 | 394,200,000 | 399,200,000 | 390,200,000 | -774,000,000 | 386,600,000 | 386,700,000 | 386,700,000 | -781,800,000 | 389,800,000 | |
| Shares (Diluted) | 390,100,000 | 393,600,000 | -817,600,000 | 407,400,000 | 408,200,000 | 407,500,000 | -831,000,000 | 410,200,000 | 416,800,000 | 416,700,000 | -851,300,000 | 426,800,000 | 431,500,000 | 418,500,000 | -848,400,000 | 425,800,000 | |
| EBITDA | $386M | $322M | · | $306M | $276M | $194M | · | $152M | $158M | $154M | · | $206M | $128M | $89M | · | $148M |
Bilans 24
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M | $939M | $851M | $566M | $644M | $1.19B | $623M | $642M | $698M | |
| Receivables | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | $1.16B | $1.01B | $1.00B | $945M | $979M | · | $786M | $751M | $637M | · | $564M | |
| Inventory | $726M | $694M | $629M | $604M | $571M | $538M | $543M | $586M | $570M | $589M | · | $499M | $421M | $366M | · | $311M | |
| Prepaid Expense | $156M | $134M | $189M | $184M | $181M | $159M | $174M | $182M | $212M | $156M | · | $174M | $195M | $198M | · | $152M | |
| Other Current Assets | $37M | $30M | $29M | $34M | $46M | $43M | $29M | $48M | $48M | $40M | · | $41M | $58M | $43M | · | $28M | |
| Current Assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B | $4.85B | $4.62B | · | $4.70B | $5.00B | $3.77B | · | $3.40B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.08B | · | $1.00B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.47B | · | $1.34B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $394M | · | $338M | |
| Goodwill | $24M | $24M | $24M | $24M | $24M | $23M | $23M | $24M | $23M | $23M | · | $25M | $26M | $26M | · | $25M | |
| Intangibles | $102M | $63M | $71M | $79M | $87M | $95M | $103M | $106M | $114M | $123M | · | $144M | $154M | $164M | · | $24M | |
| Other Non-current Assets | $274M | $286M | $279M | $276M | $176M | $168M | $173M | $88M | $83M | $78M | · | $74M | $67M | $57M | · | $34M | |
| Total Assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Current Liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | $3.04B | $2.93B | $1.73B | $1.72B | $1.59B | · | $1.68B | $2.07B | $1.86B | · | $900M | |
| Capital Leases | $83M | $69M | $73M | $51M | $55M | $60M | $65M | $71M | $77M | $76M | · | $83M | $87M | $90M | · | $82M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $151M | $142M | $137M | $147M | $152M | $150M | $148M | $130M | $128M | $129M | · | $134M | $133M | $130M | · | $123M | |
| Total Liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B | $4.36B | $4.24B | · | $4.33B | $4.72B | $3.28B | · | $3.07B | |
| Retained Earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | $1.70B | $1.60B | $1.45B | $1.31B | $1.17B | · | $765M | $644M | $528M | · | $388M | |
| Treasury Stock | $2.73B | $2.12B | $2.08B | $1.77B | $1.58B | $1.58B | $1.58B | $1.58B | $832M | $1.39B | · | $2.08B | $784M | $595M | · | $595M | |
| AOCI | $90M | $106M | $115M | $82M | $84M | $2M | $-8M | $63M | $-38M | $-37M | · | $-36M | $-29M | $-6M | · | $-41M | |
| Stockholders' Equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B | $2.43B | $2.25B | $2.07B | $2.27B | $2.10B | $2.23B | $2.13B | $1.82B | |
| Liabilities + Equity | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Shares Outstanding | 377,400,000 | 385,900,000 | 384,800,000 | 390,000,000 | 392,200,000 | 392,100,000 | 390,700,000 | 390,600,000 | 400,700,000 | 396,100,000 | 385,400,000 | 386,400,000 | 386,100,000 | 387,600,000 | 386,300,000 | 386,200,000 |
Przepływy pieniężne 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $67M | $65M | $64M | $63M | $60M | $58M | $55M | $52M | $52M | $52M | $48M | $44M | $42M | $36M | $39M | |
| Stock-based Comp | $39M | $43M | $35M | $45M | $45M | $34M | $43M | $43M | $45M | $39M | $37M | $39M | $40M | $35M | $34M | $31M | |
| Deferred Tax | $-300.0K | $300.0K | $79M | $118M | $-9M | $-6M | $24M | $-12M | $-15M | $-42M | $82M | $-85M | $-42M | $-9M | $32M | $-34M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $215M | · | · | · | $-10M | · | · | · | $13M | · | · | · | $39M | · | · | |
| Operating Cash Flow | $269M | $526M | $294M | $660M | $303M | $184M | $301M | $200M | $279M | $209M | $134M | $269M | $190M | $155M | $132M | $293M | |
| CapEx | $85M | $77M | $102M | $80M | $94M | $87M | $125M | $111M | $66M | $57M | $52M | $50M | $59M | $75M | $64M | $108M | |
| Investing Cash Flow | $330M | $-298M | $307M | $193M | $-64M | $100M | $-304M | $210M | $-189M | $75M | $415M | $-180M | $-556M | $-187M | $-194M | $229M | |
| Stock Issued | $0 | $13M | $0 | $14M | $0 | $14M | $0 | $15M | $0 | $13M | $0 | $14M | $0 | $12M | $0 | $12M | |
| Stock Repurchased | · | · | $313M | $187M | · | · | $0 | $750M | · | · | $500M | $0 | · | · | $0 | $558M | |
| Net Stock Activity | · | $13M | · | · | · | $14M | · | · | · | $13M | · | · | · | $12M | · | · | |
| Financing Cash Flow | $-607M | $-25M | $-1.52B | $-175M | $-2M | $12M | $-2M | $-736M | $-1M | $5M | $-632M | $-637M | $940M | $11M | $-1M | $-552M | |
| Net Change in Cash | $-13M | $199M | $-918M | $677M | $254M | $299M | $-15M | $-318M | $88M | $285M | $-77M | $-551M | $572M | $-19M | $-56M | $-37M | |
| Free Cash Flow | · | $449M | · | · | · | $97M | · | · | · | $152M | · | · | · | $81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $147M | · | · | · | $77M | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 62.9% | · | 60.5% | 59.5% | 56.9% | · | 59.7% | 62.4% | 61.0% | · | 63.9% | 62.7% | 62.4% | · | 64.2% | |
| Operating Margin | 24.3% | 21.4% | · | 20.1% | 18.4% | 12.9% | · | 15.3% | 15.7% | 11.0% | · | 21.1% | 14.7% | 6.4% | · | 19.2% | |
| Net Margin | 19.0% | 16.7% | · | 23.5% | 15.5% | 10.2% | · | 13.5% | 14.3% | 15.9% | · | 12.4% | 13.3% | 6.6% | · | 13.2% | |
| Pretax Margin | 24.3% | 22.6% | · | 29.1% | 20.8% | 14.9% | · | 17.8% | 18.7% | 14.4% | · | 24.7% | 18.3% | 8.7% | · | 19.0% | |
| EBITDA Margin | 29.5% | 27.1% | · | 25.3% | 23.8% | 18.7% | · | 15.3% | 15.7% | 16.7% | · | 21.1% | 14.7% | 12.0% | · | 19.2% | |
| ROA | 3.6% | 3.0% | · | 4.1% | 2.5% | 1.6% | · | 2.1% | 2.1% | 2.4% | · | 2.1% | 1.9% | 0.92% | · | 2.1% | |
| ROE | 9.6% | 7.6% | · | 12.1% | 7.2% | 4.7% | · | 6.3% | 6.3% | 6.5% | · | 5.9% | 5.3% | 2.2% | · | 5.1% | |
| ROIC | 9.5% | 6.4% | · | 7.2% | 6.2% | 4.0% | · | 5.8% | 5.0% | 5.0% | · | 4.5% | 4.4% | 1.6% | · | 5.6% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.6 | 1.5 | 1.5 | · | 2.5 | 2.8 | 2.9 | · | 2.8 | 2.4 | 2.0 | · | 3.8 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.8 | 0.7 | · | 0.9 | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.7 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 22.0 | · | 41.9 | 21.7 | 10.3 | · | 32.1 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.8 | · | 0.8 | |
| Receivables Turnover | 1.0 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.4 | 1.3 | 1.3 | · | 1.4 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.87B | $4.59B | · | $4.40B | $4.19B | $3.96B | · | $3.89B | $3.77B | $3.51B | · | $3.36B | $3.08B | $2.84B | · | $2.74B | |
| Net Income TTM | $912M | $768M | · | $704M | $563M | $530M | · | $545M | $526M | $432M | · | $386M | $317M | $298M | · | $337M | |
| Market Cap | $25.42B | $24.23B | · | $26.24B | $34.24B | $26.78B | · | $26.19B | $45.43B | $54.94B | · | $36.05B | $49.62B | $45.03B | · | $31.10B | |
| P/E | 29.3 | 32.5 | · | 38.2 | 61.9 | 51.7 | · | 50.0 | 88.6 | 132.1 | · | 100.3 | 169.1 | 163.6 | · | 100.7 | |
| P/S | 5.2 | 5.3 | · | 6.0 | 8.2 | 6.8 | · | 6.7 | 12.0 | 15.7 | · | 10.7 | 16.1 | 15.9 | · | 11.3 | |
| P/B | 9.7 | 8.2 | · | 9.6 | 13.3 | 11.8 | · | 13.2 | 18.7 | 24.5 | · | 15.9 | 23.6 | 20.2 | · | 17.0 | |
| P / Tangible Book | 10.2 | 8.4 | · | 10.0 | 13.9 | 12.5 | · | 14.2 | 19.8 | 26.2 | · | 17.2 | 25.8 | 22.0 | · | 17.5 | |
| P / Cash Flow | · | 46.1 | · | · | · | 145.7 | · | · | · | 262.6 | · | · | · | 289.8 | · | · | |
| P / FCF | · | 54.0 | · | · | · | 276.6 | · | · | · | 360.7 | · | · | · | 558.0 | · | · | |
| Earnings Yield | 3.4% | 3.1% | · | 2.6% | 1.6% | 1.9% | · | 2.0% | 1.1% | 0.76% | · | 1.0% | 0.59% | 0.61% | · | 0.99% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Marża Brutto % | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Marża Operacyjna % | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Zysk netto | $836M | $576M | $542M | $341M | $217M |
| Rozwodniony EPS | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 |
| Wskaźnik Szybkości | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $1.08B | $631M | $512M | $305M | $53M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 1 087 emitentów · $16.0B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 131 (-28 vs poprzedni kw.) | 96 (+4 vs poprzedni kw.) | 386 (+17 vs poprzedni kw.) | 352 (+6 vs poprzedni kw.) | +42.0M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1 697 876 797 | 25 209 752 | 10,61% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 323 867 969 | 19 656 540 | 8,27% | Akcje |
| STATE STREET CORP | $1 237 947 284 | 18 380 806 | 7,73% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $751 533 926 | 11 199 611 | 4,70% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $734 346 085 | 11 693 409 | 4,59% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $545 031 559 | 8 092 525 | 3,41% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $462 914 937 | 6 873 273 | 2,89% | Akcje |
| NORGES BANK | $462 565 862 | 6 868 090 | 2,89% | Akcje |
| Castle Hook Partners LP | $260 667 534 | 3 870 342 | 1,63% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $231 614 091 | 3 438 962 | 1,45% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $206 860 340 | 3 071 423 | 1,29% | Akcje |
| JANUS HENDERSON GROUP PLC | $162 720 013 | 2 591 083 | 1,02% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $152 790 681 | 2 268 607 | 0,95% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $149 327 006 | 2 217 179 | 0,93% | Akcje |
| Employees Provident Fund Board | $147 498 453 | 2 190 029 | 0,92% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $129 989 908 | 2 069 903 | 0,81% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $114 711 656 | 1 703 218 | 0,72% | Akcje |
| BLAIR WILLIAM & CO/IL | $112 182 565 | 1 665 665 | 0,70% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $109 834 111 | 1 630 796 | 0,69% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $102 869 971 | 1 527 394 | 0,64% | Akcje |
| BANK OF AMERICA CORP /DE/ | $97 103 277 | 1 441 771 | 0,61% | Akcje |
| AMERIPRISE FINANCIAL INC | $93 336 259 | 1 385 802 | 0,58% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $92 130 221 | 1 367 932 | 0,58% | Akcje |
| DSM CAPITAL PARTNERS LLC | $91 537 742 | 1 359 135 | 0,57% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $89 939 931 | 1 335 411 | 0,56% | Akcje |
| ROYAL BANK OF CANADA | $88 321 000 | 1 311 368 | 0,55% | Akcje |
| GOLDMAN SACHS GROUP INC | $87 360 493 | 1 297 112 | 0,55% | Akcje |
| CI INVESTMENTS INC. | $86 724 103 | 1 287 663 | 0,54% | Akcje |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $85 826 193 | 1 274 331 | 0,54% | Akcje |
| BANK OF NOVA SCOTIA | $85 283 937 | 1 266 285 | 0,53% | Akcje |
| DNB Asset Management AS | $84 543 377 | 1 255 284 | 0,53% | Akcje |
| Nearwater Capital Markets, Ltd | $84 187 500 | 1 250 000 | 0,53% | Akcje |
| Stephens Investment Management Group LLC | $81 126 645 | 1 204 553 | 0,51% | Akcje |
| Swedbank AB | $78 528 215 | 1 165 972 | 0,49% | Akcje |
| BlackRock, Inc. | $77 389 460 | 1 149 064 | 0,48% | Akcje |
| FMR LLC | $77 274 023 | 1 147 350 | 0,48% | Akcje |
| CITADEL ADVISORS LLC | $75 864 589 | 1 126 423 | 0,47% | Akcje |
| FIRST TRUST ADVISORS LP | $74 838 523 | 1 111 188 | 0,47% | Akcje |
| HSBC HOLDINGS PLC | $73 861 872 | 1 080 800 | 0,46% | Opcja kupna |
| Swiss National Bank | $73 108 425 | 1 085 500 | 0,46% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $71 040 241 | 1 054 792 | 0,44% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $67 343 265 | 999 900 | 0,42% | Akcje |
| CITADEL ADVISORS LLC | $64 656 000 | 960 000 | 0,40% | Opcja sprzedaży |
| Legal & General Group Plc | $64 638 083 | 959 734 | 0,40% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $64 478 600 | 957 366 | 0,40% | Akcje |
| BAILLIE GIFFORD & CO | $63 928 755 | 949 202 | 0,40% | Akcje |
| CIBC Bancorp USA Inc. | $62 958 645 | 932 286 | 0,39% | Akcje |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $61 865 555 | 918 568 | 0,39% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $59 044 465 | 876 681 | 0,37% | Akcje |
| Chicago Capital, LLC | $58 393 062 | 867 009 | 0,36% | Akcje |
| Fisher Funds Management LTD | $56 637 983 | 840 950 | 0,35% | Akcje |
| Vanguard Global Advisers, LLC | $56 107 871 | 833 079 | 0,35% | Akcje |
| JANE STREET GROUP, LLC | $56 062 140 | 832 400 | 0,35% | Opcja kupna |
| Bellevue Group AG | $55 394 634 | 822 489 | 0,35% | Akcje |
| Tri Locum Partners LP | $55 259 261 | 820 479 | 0,35% | Akcje |
| RHUMBLINE ADVISERS | $51 735 803 | 768 165 | 0,32% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $51 168 667 | 759 743 | 0,32% | Akcje |
| UBS Group AG | $51 066 858 | 758 231 | 0,32% | Akcje |
| Allianz Asset Management GmbH | $50 820 963 | 809 251 | 0,32% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $50 518 000 | 750 088 | 0,32% | Akcje |
| BARCLAYS PLC | $50 351 331 | 747 607 | 0,31% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $49 968 851 | 741 928 | 0,31% | Akcje |
| TWO SIGMA ADVISERS, LP | $49 649 804 | 748 076 | 0,31% | Akcje |
| Smith Group Asset Management, LLC | $47 235 720 | 701 347 | 0,30% | Akcje |
| NATIONAL BANK OF CANADA /FI/ | $46 761 576 | 694 307 | 0,29% | Akcje |
| Assenagon Asset Management S.A. | $46 716 317 | 693 635 | 0,29% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $46 117 886 | 684 750 | 0,29% | Akcje |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $44 760 810 | 664 600 | 0,28% | Akcje |
| PEREGRINE CAPITAL MANAGEMENT LLC | $44 759 530 | 664 581 | 0,28% | Akcje |
| Capital International Investors | $44 585 633 | 661 999 | 0,28% | Akcje |
| CAPITAL FUND MANAGEMENT S.A. | $44 543 875 | 661 379 | 0,28% | Akcje |
| Pictet Asset Management Holding SA | $44 534 379 | 661 238 | 0,28% | Akcje |
| National Pension Service | $44 471 811 | 660 309 | 0,28% | Akcje |
| California Public Employees Retirement System | $42 988 899 | 638 291 | 0,27% | Akcje |
| Korea Investment CORP | $42 608 237 | 632 639 | 0,27% | Akcje |
| ING GROEP NV | $41 334 513 | 613 727 | 0,26% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $41 226 753 | 612 127 | 0,26% | Akcje |
| MIG Capital, LLC | $40 190 154 | 605 547 | 0,25% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $39 472 718 | 584 004 | 0,25% | Akcje |
| Quantinno Capital Management LP | $39 303 248 | 583 567 | 0,25% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $36 898 831 | 587 561 | 0,23% | Akcje |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $36 855 267 | 547 220 | 0,23% | Akcje |
| FACTORY MUTUAL INSURANCE CO | $36 222 851 | 537 830 | 0,23% | Akcje |
| Woodline Partners LP | $36 146 880 | 536 702 | 0,23% | Akcje |
| Parkman Healthcare Partners LLC | $36 016 557 | 534 767 | 0,23% | Akcje |
| MARSHALL WACE, LLP | $35 884 349 | 532 804 | 0,22% | Akcje |
| Walleye Trading LLC | $35 823 465 | 531 900 | 0,22% | Opcja kupna |
| EVENTIDE ASSET MANAGEMENT, LLC | $33 574 377 | 498 202 | 0,21% | Akcje |
| Blue Sparrow, LLC /DE | $32 368 410 | 480 600 | 0,20% | Akcje |
| Trexquant Investment LP | $31 938 380 | 474 215 | 0,20% | Akcje |
| Cubist Systematic Strategies, LLC | $31 905 647 | 474 151 | 0,20% | Akcje |
| UBS Group AG | $31 896 960 | 473 600 | 0,20% | Opcja sprzedaży |
| Mitsubishi UFJ Trust & Banking Corp | $31 227 164 | 463 655 | 0,20% | Akcje |
| USS Investment Management Ltd | $30 910 132 | 459 050 | 0,19% | Akcje |
| OFI INVEST ASSET MANAGEMENT | $29 454 211 | 500 000 | 0,18% | Akcje |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $29 397 534 | 436 489 | 0,18% | Akcje |
| ProShare Advisors LLC | $28 566 636 | 424 152 | 0,18% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $28 528 135 | 427 840 | 0,18% | Akcje |
| SIRIOS CAPITAL MANAGEMENT L P | $28 315 152 | 420 418 | 0,18% | Akcje |
| Bridgewater Associates, LP | $27 002 568 | 400 929 | 0,17% | Akcje |
Insiderzy spółki 60 insiderów · 36 dyrektorzy generalni · 23 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jacob Steven Leach | President, CEO, and Director | 22 maja 2026 F | 420 359 | 2 | 0 | $1 001 761 |
| Andrew P Rasdal | President & CEO | 2 maja 2006 M | 2 944 | 0 | 0 | $0 |
| Jess Roper | SVP, CFO | 22 marca 2017 S | 8 452 | 0 | 0 | $0 |
| Steven J Kemper | Chief Financial Officer | 15 maja 2007 A | 26 255 | 0 | 0 | $0 |
| Quentin S. Blackford | Chief Operating Officer | 10 września 2021 S | 19 280 | 0 | 0 | $0 |
| Kevin R Sayer | Executive Chair | 20 lipca 2026 S | 328 970 | 0 | 3 | $-5 895 098 |
| Jon Coleman | EVP, Chief Commercial Officer | 4 czerwca 2026 S | 95 450 | 0 | 2 | $-722 628 |
| Sadie Stern | EVP Chief People & Culture Off | 22 maja 2026 F | 130 059 | 0 | 1 | $-117 280 |
| Jereme M Sylvain | EVP, Chief Financal Officer | 22 maja 2026 F | 151 841 | 0 | 1 | $-357 796 |
| Matthew Vincent Dolan | EVP, Strategy & Corporate Dev | 29 stycznia 2025 S | 42 044 | 0 | 0 | $0 |
| Teri L Lawver | EVP Chief Commercial Officer | 12 marca 2024 S | 66 641 | 0 | 0 | $0 |
| Paul R Flynn | EVP Global Revenue | 18 grudnia 2023 D | 48 949 | 0 | 0 | $0 |
| Barry J. Regan | EVP Operations | 18 grudnia 2023 D | 58 469 | 0 | 0 | $0 |
| Steven Robert Pacelli | EVP Managing Director Dexcom V | 24 listopada 2023 S | 124 775 | 0 | 0 | $0 |
| Girish Naganathan | EVP Chief Technology Officer | 9 listopada 2023 S | 47 725 | 0 | 0 | $0 |
| Shelly Ramasamy Selvaraj | SVP Chief Information Officer | 11 września 2023 D | 48 453 | 0 | 0 | $0 |
| Donald Abbey | EVP Global Business Services I | 10 marca 2023 D | 208 023 | 0 | 0 | $0 |
| Andrew K Balo | EVP Regulatory Strategy Clinic | 10 marca 2023 D | 50 908 | 0 | 0 | $0 |
| Chad Patterson | EVP Global Marketing | 9 maja 2022 S | 13 675 | 0 | 0 | $0 |
| Sumi Shrishrimal | SVP Chief Risk Officer | 9 marca 2022 D | 13 789 | 0 | 0 | $0 |
| Patrick Michael Murphy | EVP, Chief Legal Officer | 9 września 2021 S | 16 254 | 0 | 0 | $0 |
| Richard Doubleday | EVP Chief Commercial Officer | 23 marca 2021 S | 6 654 | 0 | 0 | $0 |
| Jeffrey Moy | EVP Operations | 9 września 2020 D | 34 784 | 0 | 0 | $0 |
| Heather S Ace | SVP Human Resources | 11 marca 2020 S | 38 584 | 0 | 0 | $0 |
| Terrance H Gregg | Executive Chairman | 16 lipca 2018 S | 50 882 | 0 | 0 | $0 |
| John Lister | General Manager, EMEA | 9 marca 2017 M | 84 034 | 0 | 0 | $0 |
| Peter Gerhardsson | VP, Int'l Bus. Dev. | 16 listopada 2010 P | 3 387 | 0 | 0 | $0 |
| David Carner | VP, Quality Assurance | 16 sierpnia 2010 A | — | 0 | 0 | $0 |
| Laura Johnson | V.P., Intellectual Property | 12 marca 2010 A | — | 0 | 0 | $0 |
| Richard Yang | V.P., Strategic Affairs | 12 marca 2010 A | — | 0 | 0 | $0 |
| Claudia Graham | VP Marketing | 12 marca 2010 A | 18 741 | 0 | 0 | $0 |
| Rodney L Kellogg | Vice President of Sales | 19 maja 2008 A | — | 0 | 0 | $0 |
| James H Brauker | VP Research & Development | 24 marca 2008 A | 53 125 | 0 | 0 | $0 |
| Mark Brister | VP, Advanced Development Team | 2 listopada 2007 A | 10 967 | 0 | 0 | $0 |
| John Riolo | VP of Quality Assurance | 2 sierpnia 2007 A | — | 0 | 0 | $0 |
| Tae Andrews | Vice President of Marketing | 9 marca 2007 A | — | 0 | 0 | $0 |
| Mark G Foletta | Dyrektor | 3 sierpnia 2026 S | 48 852 | 0 | 4 | $-627 183 |
| Albert Frederick Osterloh IV | Dyrektor | 28 maja 2026 A | 8 691 | 0 | 0 | $0 |
| Euan A. Ashley | Dyrektor | 28 maja 2026 A | 12 731 | 0 | 0 | $0 |
| Rimma Driscoll | Dyrektor | 28 maja 2026 A | 17 319 | 0 | 0 | $0 |
| Kyle Malady | Dyrektor | 28 maja 2026 A | 28 242 | 0 | 1 | $-53 934 |
| Richard Alexander Collins | Dyrektor | 28 maja 2026 A | 5 605 | 0 | 2 | $-389 410 |
| Renee D Gala | Dyrektor | 28 maja 2026 A | 12 486 | 0 | 0 | $0 |
| Steven R Altman | Dyrektor | 28 maja 2026 A | 5 565 | 0 | 0 | $0 |
| Karen M Dahut | Dyrektor | 8 maja 2025 G | 17 779 | 0 | 0 | $0 |
| Eric Topol | Dyrektor | 8 maja 2025 G | 380 545 | 0 | 0 | $0 |
| Barbara Kahn | Dyrektor | 18 maja 2024 G | 22 575 | 0 | 0 | $0 |
| Jay S Skyler | Dyrektor | 18 maja 2023 G | 63 348 | 0 | 0 | $0 |
| Jonathan T Lord MD | Dyrektor | 1 września 2016 S | 52 820 | 0 | 0 | $0 |
| Martin Doordan | Dyrektor | 1 czerwca 2012 A | 39 633 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 197 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| TMFM · RBB Fund, Inc. | 5,18% | 81 981 NS | 31 maja 2026 | N-PORT |
| HEAL · Global X Funds | 4,89% | 16 599 NS | 31 maja 2026 | N-PORT |
| SNSR · Global X Funds | 4,74% | 161 491 NS | 31 maja 2026 | N-PORT |
| IHI · iShares Trust | 4,54% | 1 828 483 SH | 8 sierpnia 2026 | Dziennie |
| GDOC · Goldman Sachs ETF Trust | 2,79% | 7 621 NS | 31 maja 2026 | N-PORT |
| TMFG · RBB Fund, Inc. | 2,33% | 112 503 NS | 31 maja 2026 | N-PORT |
| AGNG · Global X Funds | 2,01% | 22 316 NS | 31 maja 2026 | N-PORT |
| HRTS · Tema ETF Trust | 1,92% | 13 512 NS | 31 maja 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 1,91% | 5 848 NS | 30 kwietnia 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,89% | 952 NS | 30 kwietnia 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,72% | 158 549 SH | 8 sierpnia 2026 | Dziennie |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,42% | 389 654 SH | 8 sierpnia 2026 | Dziennie |
| TMFX · RBB Fund, Inc. | 1,37% | 5 955 NS | 31 maja 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,18% | 6 533 NS | 31 maja 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1,17% | 15 853 NS | 31 maja 2026 | N-PORT |
| DTEC · ALPS ETF Trust | 1,01% | 10 206 NS | 31 maja 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 1,01% | 302 231 NS | 31 maja 2026 | N-PORT |
| LGRO · ALPS ETF Trust | 1,00% | 18 376 NS | 31 maja 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 0,99% | 1 867 NS | 30 kwietnia 2026 | N-PORT |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 0,97% | 17 329 NS | 30 kwietnia 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 0,92% | 6 459 NS | 30 kwietnia 2026 | N-PORT |
| MMID · MFS Active Exchange Traded Funds Tr… | 0,91% | 4 208 NS | 31 maja 2026 | N-PORT |
| IWP · iShares Trust | 0,91% | 2 217 346 SH | 8 sierpnia 2026 | Dziennie |
| SDG · iShares Trust | 0,87% | 18 232 SH | 8 sierpnia 2026 | Dziennie |
| MEDI · Harbor ETF Trust | 0,84% | 3 888 NS | 30 kwietnia 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0,80% | 163 528 NS | 30 kwietnia 2026 | N-PORT |
| FWD · AB Active ETFs, Inc. | 0,76% | 296 418 NS | 31 maja 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,67% | 56 679 NS | 31 maja 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,64% | 1 196 NS | 30 kwietnia 2026 | N-PORT |
| QNXT · iShares Trust | 0,59% | 2 014 SH | 8 sierpnia 2026 | Dziennie |
| VOT · VANGUARD INDEX FUNDS | 0,57% | 2 956 203 SH | 8 sierpnia 2026 | Dziennie |
| IYH · iShares Trust | 0,52% | 229 458 SH | 8 sierpnia 2026 | Dziennie |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,46% | 1 074 035 SH | 8 sierpnia 2026 | Dziennie |
| IMCG · iShares Trust | 0,43% | 209 424 SH | 8 sierpnia 2026 | Dziennie |
| RXL · ProShares Trust | 0,41% | 4 013 NS | 31 maja 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,41% | 2 617 NS | 30 kwietnia 2026 | N-PORT |
| IXJ · iShares Trust | 0,40% | 202 443 SH | 8 sierpnia 2026 | Dziennie |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,38% | 56 496 NS | 30 kwietnia 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,38% | 1 156 710 SH | 8 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,38% | 179 798 NS | 30 kwietnia 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,34% | 23 742 SH | 8 sierpnia 2026 | Dziennie |
| MMLG · First Trust Exchange-Traded Fund VI… | 0,33% | 4 233 NS | 31 maja 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,33% | 18 233 NS | 31 maja 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,33% | 7 675 NS | 30 kwietnia 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,32% | 11 239 NS | 31 maja 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,32% | 9 251 NS | 31 maja 2026 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,32% | 558 304 NS | 31 maja 2026 | N-PORT |
| TMFE · RBB Fund, Inc. | 0,32% | 3 671 NS | 31 maja 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,30% | 64 292 NS | 30 kwietnia 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,26% | 7 662 NS | 31 maja 2026 | N-PORT |